PL 01 - Plenary

Presentations

• 01:30pm - 03:00pm PT

  Plenary

  Speaker: Farzan Siddiqui, MD, PhD, FASTRO - Henry Ford Hospital/Wayne State University, Detroit
• 01:30pm - 03:00pm PT

  Plenary

  Speaker: Kenneth Rosenzweig, MD, FASTRO - Icahn School of Medicine at Mount Sinai, New York
• 01:30pm - 01:40pm PT

  PHASE III RANDOMIZED TRIAL OF PROTON VS. PHOTON THERAPY FOR PATIENTS WITH NON-METASTATIC BREAST CANCER RECEIVING COMPREHENSIVE NODAL RADIATION: A RADIOTHERAPY COMPARATIVE EFFECTIVENESS (RADCOMP) CONSORTIUM TRIAL: HEALTH-RELATED QUALITY OF LIFE OUTCOMES

  Speaker: Shannon MacDonald, MD, FASTRO - Massachusetts General Hospital, Boston
• 01:40pm - 01:50pm PT

  Primary results for the phase III trial of Toxicity Reduction using Proton Beam Therapy for Oropharyngeal Cancer (TORPEdO; CRUK/18/010)

  Speaker: David Thomson, - The Christie NHS Foundation Trust, Manchester
• 01:50pm - 02:00pm PT

  Primary Results from NRG-GU005: A Phase III Trial of SBRT vs. Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer

  Speaker: Rodney Ellis, - University of South Florida/Tampa GeneralHospital, Tampa
• 02:00pm - 02:10pm PT

  Bladder Adjuvant Radiotherapy (BART): Clinical Outcomes from a Phase III Multicenter Randomized Controlled Trial

  Speaker: Vedang Murthy, MD - Tata Memorial Centre, New Mumbai
• 02:10pm - 02:20pm PT

  Tumor Treating Fields (TTFields) After Stereotactic Radiosurgery (SRS) for Brain Metastases from Non-Small Cell Lung Cancer (NSCLC BM): Final Results of The Phase 3 METIS Trial

  Speaker: Vinai Gondi, MD - Northwestern Medicine Warrenville Cancer Center and Proton Center, Warrenville